Actinogen Other Stockholder Equity vs Short Term Investments Analysis

ACW Stock

0.03 0 3.85%

Actinogen Medical financial indicator trend analysis is way more than just evaluating Actinogen Medical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Actinogen Medical is a good investment. Please check the relationship between Actinogen Medical Other Stockholder Equity and its Short Term Investments accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Actinogen Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Other Stockholder Equity vs Short Term Investments

Other Stockholder Equity vs Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Actinogen Medical Other Stockholder Equity account and Short Term Investments. At this time, the significance of the direction appears to have strong relationship.

The correlation between Actinogen Medical's Other Stockholder Equity and Short Term Investments is 0.76. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of Actinogen Medical, assuming nothing else is changed. The correlation between historical values of Actinogen Medical's Other Stockholder Equity and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of Actinogen Medical are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Other Stockholder Equity i.e., Actinogen Medical's Other Stockholder Equity and Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.76

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Other Stockholder Equity

Short Term Investments

Short Term Investments is an item under the current assets section of Actinogen Medical balance sheet. It contains any investments Actinogen Medical undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Actinogen Medical can easily liquidate in the marketplace.

Most indicators from Actinogen Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Actinogen Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Actinogen Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to drop to about 1.3 M in 2025. Issuance Of Capital Stock is likely to drop to about 11.5 M in 2025

	2022	2023	2024	2025 (projected)
Total Revenue	4.9M	9.9M	11.4M	12.0M
Depreciation And Amortization	405.6K	416.8K	479.4K	244.7K

Total Revenue Depreciation And Amortization

Actinogen Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Cash	Net Receivables	Total Liab	Common Stock	Property Plant Equipment	Other Current Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Non Current Assets Total	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Inventory	Other Stockholder Equity	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Non Currrent Assets Other	Net Tangible Assets	Short Term Investments
Total Assets		0.76	0.83	1.0	0.88	0.79	0.84	0.9	0.24	0.27	0.59	-0.81	-0.84	0.64	0.57	0.84	0.93	0.89	0.69	-0.87	0.64	0.97	0.29	-0.17	0.91	-0.74
Other Current Liab	0.76		0.89	0.74	0.61	0.89	0.94	0.94	0.24	0.09	0.7	-0.5	-0.94	0.5	0.13	0.47	0.85	0.95	0.75	-0.87	0.76	0.82	-0.11	0.22	0.59	-0.74
Total Current Liabilities	0.83	0.89		0.8	0.67	0.79	0.99	0.91	0.06	0.35	0.43	-0.58	-0.91	0.83	0.31	0.62	0.84	0.92	0.8	-0.85	0.51	0.84	0.06	-0.03	0.71	-0.75
Total Stockholder Equity	1.0	0.74	0.8		0.89	0.77	0.82	0.89	0.25	0.26	0.59	-0.82	-0.82	0.63	0.59	0.84	0.92	0.87	0.67	-0.86	0.63	0.97	0.31	-0.19	0.91	-0.73
Cash	0.88	0.61	0.67	0.89		0.55	0.68	0.77	0.34	0.07	0.52	-0.98	-0.74	0.52	0.39	0.94	0.82	0.76	0.43	-0.69	0.55	0.89	0.17	-0.13	0.95	-0.68
Net Receivables	0.79	0.89	0.79	0.77	0.55		0.84	0.93	0.11	0.16	0.7	-0.42	-0.86	0.44	0.14	0.42	0.77	0.91	0.84	-0.82	0.77	0.85	-0.04	0.34	0.54	-0.6
Total Liab	0.84	0.94	0.99	0.82	0.68	0.84		0.95	0.1	0.26	0.51	-0.58	-0.94	0.75	0.29	0.61	0.87	0.96	0.82	-0.88	0.59	0.87	0.03	0.02	0.7	-0.76
Common Stock	0.9	0.94	0.91	0.89	0.77	0.93	0.95		0.17	0.14	0.66	-0.66	-0.96	0.6	0.25	0.65	0.9	0.99	0.78	-0.9	0.73	0.94	0.03	0.16	0.74	-0.74
Property Plant Equipment	0.24	0.24	0.06	0.25	0.34	0.11	0.1	0.17		0.19	0.76	-0.34	-0.22	-0.11	0.13	0.27	0.45	0.17	-0.09	-0.24	0.69	0.22	0.05	0.02	0.4	-0.53
Other Current Assets	0.27	0.09	0.35	0.26	0.07	0.16	0.26	0.14	0.19		0.08	-0.09	-0.14	0.56	0.44	0.19	0.3	0.14	0.4	-0.21	0.08	0.2	0.23	-0.3	0.29	-0.29
Property Plant And Equipment Net	0.59	0.7	0.43	0.59	0.52	0.7	0.51	0.66	0.76	0.08		-0.43	-0.64	0.03	0.07	0.35	0.71	0.64	0.41	-0.61	0.99	0.63	-0.06	0.33	0.5	-0.67
Net Debt	-0.81	-0.5	-0.58	-0.82	-0.98	-0.42	-0.58	-0.66	-0.34	-0.09	-0.43		0.65	-0.51	-0.38	-0.96	-0.75	-0.65	-0.36	0.6	-0.45	-0.82	-0.15	0.18	-0.94	0.64
Retained Earnings	-0.84	-0.94	-0.91	-0.82	-0.74	-0.86	-0.94	-0.96	-0.22	-0.14	-0.64	0.65		-0.63	-0.19	-0.65	-0.89	-0.98	-0.73	0.89	-0.71	-0.89	0.05	-0.18	-0.73	0.79
Accounts Payable	0.64	0.5	0.83	0.63	0.52	0.44	0.75	0.6	-0.11	0.56	0.03	-0.51	-0.63		0.44	0.63	0.6	0.62	0.62	-0.62	0.09	0.61	0.22	-0.32	0.65	-0.59
Non Current Assets Total	0.57	0.13	0.31	0.59	0.39	0.14	0.29	0.25	0.13	0.44	0.07	-0.38	-0.19	0.44		0.51	0.51	0.24	0.23	-0.45	0.06	0.39	0.71	-0.81	0.53	-0.39
Cash And Short Term Investments	0.84	0.47	0.62	0.84	0.94	0.42	0.61	0.65	0.27	0.19	0.35	-0.96	-0.65	0.63	0.51		0.75	0.65	0.41	-0.63	0.38	0.82	0.24	-0.31	0.96	-0.66
Common Stock Total Equity	0.93	0.85	0.84	0.92	0.82	0.77	0.87	0.9	0.45	0.3	0.71	-0.75	-0.89	0.6	0.51	0.75		0.91	0.64	-0.89	0.75	0.91	0.22	-0.11	0.86	-0.87
Common Stock Shares Outstanding	0.89	0.95	0.92	0.87	0.76	0.91	0.96	0.99	0.17	0.14	0.64	-0.65	-0.98	0.62	0.24	0.65	0.91		0.78	-0.89	0.71	0.93	0.01	0.16	0.74	-0.76
Inventory	0.69	0.75	0.8	0.67	0.43	0.84	0.82	0.78	-0.09	0.4	0.41	-0.36	-0.73	0.62	0.23	0.41	0.64	0.78		-0.69	0.49	0.75	-0.04	0.11	0.47	-0.59
Other Stockholder Equity	-0.87	-0.87	-0.85	-0.86	-0.69	-0.82	-0.88	-0.9	-0.24	-0.21	-0.61	0.6	0.89	-0.62	-0.45	-0.63	-0.89	-0.89	-0.69		-0.66	-0.85	-0.36	0.07	-0.72	0.76
Property Plant And Equipment Gross	0.64	0.76	0.51	0.63	0.55	0.77	0.59	0.73	0.69	0.08	0.99	-0.45	-0.71	0.09	0.06	0.38	0.75	0.71	0.49	-0.66		0.69	-0.09	0.36	0.53	-0.68
Total Current Assets	0.97	0.82	0.84	0.97	0.89	0.85	0.87	0.94	0.22	0.2	0.63	-0.82	-0.89	0.61	0.39	0.82	0.91	0.93	0.75	-0.85	0.69		0.13	0.01	0.89	-0.73
Intangible Assets	0.29	-0.11	0.06	0.31	0.17	-0.04	0.03	0.03	0.05	0.23	-0.06	-0.15	0.05	0.22	0.71	0.24	0.22	0.01	-0.04	-0.36	-0.09	0.13		-0.64	0.25	-0.12
Non Currrent Assets Other	-0.17	0.22	-0.03	-0.19	-0.13	0.34	0.02	0.16	0.02	-0.3	0.33	0.18	-0.18	-0.32	-0.81	-0.31	-0.11	0.16	0.11	0.07	0.36	0.01	-0.64		-0.25	0.08
Net Tangible Assets	0.91	0.59	0.71	0.91	0.95	0.54	0.7	0.74	0.4	0.29	0.5	-0.94	-0.73	0.65	0.53	0.96	0.86	0.74	0.47	-0.72	0.53	0.89	0.25	-0.25		-0.73
Short Term Investments	-0.74	-0.74	-0.75	-0.73	-0.68	-0.6	-0.76	-0.74	-0.53	-0.29	-0.67	0.64	0.79	-0.59	-0.39	-0.66	-0.87	-0.76	-0.59	0.76	-0.68	-0.73	-0.12	0.08	-0.73

Click cells to compare fundamentals

Actinogen Medical Account Relationship Matchups

Actinogen Medical fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	18.4M	23.3M	15.2M	21.3M	24.5M	25.7M
Other Current Liab	291.7K	502.5K	613.2K	699.1K	803.9K	844.1K
Total Current Liabilities	755.1K	1.5M	1.8M	1.4M	1.6M	1.6M
Total Stockholder Equity	17.5M	21.7M	13.4M	19.7M	22.7M	23.8M
Cash	13.4M	16.4M	8.5M	9.5M	10.9M	11.4M
Net Receivables	1.5M	3.9M	3.9M	9.4M	10.8M	11.4M
Total Liab	920.3K	1.6M	1.8M	1.6M	1.9M	2.0M
Common Stock	60.1M	76.9M	78.7M	100.0M	115.0M	120.8M
Other Current Assets	90.0K	104.6K	344.5K	108.8K	125.2K	134.7K
Property Plant And Equipment Net	254.0K	169.0K	112.7K	341.5K	392.7K	412.3K
Net Debt	(13.2M)	(16.2M)	(8.4M)	(9.1M)	(8.2M)	(8.6M)
Retained Earnings	(48.4M)	(57.9M)	(68.7M)	(81.7M)	(73.6M)	(69.9M)
Accounts Payable	392.2K	898.7K	1.1M	597.2K	686.8K	353.5K
Non Current Assets Total	3.3M	2.9M	2.5M	2.4M	2.8M	2.6M
Cash And Short Term Investments	13.4M	16.4M	8.5M	9.5M	10.9M	6.3M
Common Stock Shares Outstanding	1.5B	1.8B	1.9B	2.2B	2.5B	2.6B
Liabilities And Stockholders Equity	18.4M	23.3M	15.2M	21.3M	24.5M	25.7M
Other Stockholder Equity	(1.9M)	(6.3M)	(7.2M)	(10.5M)	(9.4M)	(9.0M)
Property Plant And Equipment Gross	266.4K	188.3K	143.9K	393.7K	452.8K	475.4K
Total Current Assets	15.1M	20.4M	12.7M	18.9M	21.7M	22.8M
Accumulated Other Comprehensive Income	7.8M	9.1M	10.6M	1.4M	1.6M	1.5M
Intangible Assets	3.0M	2.7M	2.4M	2.1M	2.4M	2.7M
Non Currrent Assets Other	(3.3M)	(2.9M)	(2.5M)	(1.0)	(1.15)	(1.21)
Net Tangible Assets	7.5M	14.4M	19.0M	11.0M	12.6M	10.9M
Non Current Liabilities Total	165.3K	86.9K	86.9K	258.4K	297.2K	312.0K
Short Term Debt	71.2K	78.3K	86.9K	60.7K	54.6K	51.9K
Net Invested Capital	17.5M	21.7M	13.4M	19.7M	22.7M	17.3M
Cash And Equivalents	3.6M	7.1M	12.1M	7.2M	8.3M	7.8M
Net Working Capital	14.3M	18.9M	10.9M	17.5M	20.1M	13.5M
Short Long Term Debt Total	236.4K	165.3K	86.9K	319.1K	287.2K	211.7K
Current Deferred Revenue	(71.2K)	(78.3K)	(86.9K)	582.2K	669.5K	703.0K
Capital Stock	60.1M	76.9M	78.7M	100.0M	115.0M	75.5M
Capital Lease Obligations	236.4K	165.3K	86.9K	319.1K	287.2K	191.6K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Actinogen Stock Analysis

When running Actinogen Medical's price analysis, check to measure Actinogen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinogen Medical is operating at the current time. Most of Actinogen Medical's value examination focuses on studying past and present price action to predict the probability of Actinogen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinogen Medical's price. Additionally, you may evaluate how the addition of Actinogen Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC